Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Depression: HELP
Husseini K. Manji
Based on 30 articles published since 2008
||||
Expertise Level
The expertise of Husseini K. Manji ranks in the
  • Top 0.23%
  • ... of 220,141 published authors worldwide on Depression
  • ... from 2008 through 2019
  • ... based on contributions to 30 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Manji, Husseini K   ·   Manji, H K   ·   Manji, H   ·   Manji, Husseini
Work Locations
Details
Most likely:    Miscellaneous institutions in San Diego      
2016
  • Janssen Research & Development, LLC, San Diego, California. Electronic address: · Janssen Research & Development, LLC, San Diego, California. · Janssen-Cilag B.V., Tilburg, Netherlands. · Psychiatric Hospital Zoete Nood Gods, Lede, Belgium. · Department of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany. · Department of Mood Disorders, University Psychiatric Centre, Katholieke Universiteit Leuven (University of Leuven), Leuven. · Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium. · Pubmed 26707087
2010
  • Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, La Jolla, CA 92121, USA. · Pubmed 20962329
Probable:    Johnson and Johnson USA      
2015
  • Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States. Electronic address: · Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States. · Neuroscience at Janssen Pharmaceutical Companies of Johnson & Johnson, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States. · Pubmed 26432926
  • University of Maryland School of Medicine, Department of Psychiatry, Baltimore, MD, USA; Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. · Université Paris Sud, INSERM UMR S 1178, Faculté de Pharmacie, Châtenay-Malabry, France. · Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. · Global Therapeutic Area Head, Neuroscience, Janssen Research & Development, Titusville, NJ, USA. · Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA; Departments of Psychiatry and Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: · Pubmed 26138027
2016
  • From Janssen Research and Development, Titusville, N.J., and Beerse, Belgium; the Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, N.Y.; the Department of Psychiatry, Yale University, New Haven, Conn.; the Department of Psychiatry and Behavioral Neurobiology, School of Medicine, University of Alabama at Birmingham; the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas; the Institute of Living, Hartford, Conn.; University of Connecticut Health Center, Farmington; the Department of Psychiatry, Massachusetts General Hospital, Boston. · Pubmed 27056608
Probable:    National Institutes of Health      
2014
  • Department of Clinical Neuroscience, Stockholm, Sweden. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD, USA. · Department of Psychiatry and the Mood Disorders Research Program and Clinic, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA. · Pubmed 24614495
2013
  • Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. · Pubmed 22676966
2012
  • Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Programs, National Institute of Mental Health-NIMH, National Institutes of Health-NIH, Bethesda, MD, USA. · Pubmed 22298121
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. · Pubmed 21906419
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD, USA. · Pubmed 21727899
2011
  • Mood and Anxiety Disorders Program, National Institutes of Health/National Institute of Mental Health, Bethesda, Maryland, USA. · Pubmed 21094939
2010
  • Mood and Anxiety Disorders Program, NIMH, 15K North Dr., MSC 2670, Bethesda, MD 20892, USA. · Pubmed 20439387
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Bethesda, MD 20892, USA. · Pubmed 20308988
  • Unit on the Genetic Basis of Mood and Anxiety Disorders, National Institute of Mental Health, Bethesda, MD 20892-3719, USA. · Pubmed 20047709
  • Section on Neuroimaging in Mood and Anxiety Disorders, NIH/NIMH/MAP, Bethesda, MD 20892, USA. · Pubmed 19931399
  • Biomarker Laboratory, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19913919
2009
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19407332
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19269045
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19224657
  • Mood and Anxiety Disorders Program, Laboratory of Molecular Psychiatry and Experimental Therapeutics, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, Maryland, USA. · Pubmed 19744406
  • Genetic Basis of Mood and Anxiety Disorders Unit, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA. · Pubmed 19724244
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health/DHHS, 10 Center Drive, Bethesda, MD 20892-1282, USA. · Pubmed 18996507
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. · Pubmed 18822408
2008
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Mood and Anxiety Disorders Research Program, National Institute of Mental Health, Bethesda, MD, USA. · Pubmed 18704977
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, Department of Health and Human Services, Bethesda, MD 20892-1282, USA. · Pubmed 18435563
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. · Pubmed 18562287
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 30 total) written by Husseini K. Manji about Depression:

  • A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. 2016
  • Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. 2016
  • Translating depression biomarkers for improved targeted therapies. 2015
  • Antidepressant-like Effects of Electroconvulsive Seizures Require Adult Neurogenesis in a Neuroendocrine Model of Depression. 2015
  • Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. 2014
  • Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. 2013
  • Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. 2013
  • Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. 2012
  • Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. 2012
  • Acute D-serine treatment produces antidepressant-like effects in rodents. 2012
Show List of Full Article Records
Google Searches

Learn more about Husseini K. Manji using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in San Diego
Johnson and Johnson USA
National Institutes of Health
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in San Diego
2016
  • Janssen Research & Development, LLC, San Diego, California. Electronic address: · Janssen Research & Development, LLC, San Diego, California. · Janssen-Cilag B.V., Tilburg, Netherlands. · Psychiatric Hospital Zoete Nood Gods, Lede, Belgium. · Department of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany. · Department of Mood Disorders, University Psychiatric Centre, Katholieke Universiteit Leuven (University of Leuven), Leuven. · Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium. · Pubmed 26707087
2010
  • Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, La Jolla, CA 92121, USA. · Pubmed 20962329
Johnson and Johnson USA
2015
  • Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States. Electronic address: · Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States. · Neuroscience at Janssen Pharmaceutical Companies of Johnson & Johnson, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States. · Pubmed 26432926
  • University of Maryland School of Medicine, Department of Psychiatry, Baltimore, MD, USA; Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. · Université Paris Sud, INSERM UMR S 1178, Faculté de Pharmacie, Châtenay-Malabry, France. · Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. · Global Therapeutic Area Head, Neuroscience, Janssen Research & Development, Titusville, NJ, USA. · Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA; Departments of Psychiatry and Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: · Pubmed 26138027
2016
  • From Janssen Research and Development, Titusville, N.J., and Beerse, Belgium; the Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, N.Y.; the Department of Psychiatry, Yale University, New Haven, Conn.; the Department of Psychiatry and Behavioral Neurobiology, School of Medicine, University of Alabama at Birmingham; the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas; the Institute of Living, Hartford, Conn.; University of Connecticut Health Center, Farmington; the Department of Psychiatry, Massachusetts General Hospital, Boston. · Pubmed 27056608
National Institutes of Health
2014
  • Department of Clinical Neuroscience, Stockholm, Sweden. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD, USA. · Department of Psychiatry and the Mood Disorders Research Program and Clinic, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA. · Pubmed 24614495
2013
  • Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. · Pubmed 22676966
2012
  • Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Programs, National Institute of Mental Health-NIMH, National Institutes of Health-NIH, Bethesda, MD, USA. · Pubmed 22298121
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. · Pubmed 21906419
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD, USA. · Pubmed 21727899
2011
  • Mood and Anxiety Disorders Program, National Institutes of Health/National Institute of Mental Health, Bethesda, Maryland, USA. · Pubmed 21094939
2010
  • Mood and Anxiety Disorders Program, NIMH, 15K North Dr., MSC 2670, Bethesda, MD 20892, USA. · Pubmed 20439387
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Bethesda, MD 20892, USA. · Pubmed 20308988
  • Unit on the Genetic Basis of Mood and Anxiety Disorders, National Institute of Mental Health, Bethesda, MD 20892-3719, USA. · Pubmed 20047709
  • Section on Neuroimaging in Mood and Anxiety Disorders, NIH/NIMH/MAP, Bethesda, MD 20892, USA. · Pubmed 19931399
  • Biomarker Laboratory, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19913919
2009
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19407332
  • Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Intramural Research Program, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19269045
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 19224657
  • Mood and Anxiety Disorders Program, Laboratory of Molecular Psychiatry and Experimental Therapeutics, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, Maryland, USA. · Pubmed 19744406
  • Genetic Basis of Mood and Anxiety Disorders Unit, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA. · Pubmed 19724244
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health/DHHS, 10 Center Drive, Bethesda, MD 20892-1282, USA. · Pubmed 18996507
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. · Pubmed 18822408
2008
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Mood and Anxiety Disorders Research Program, National Institute of Mental Health, Bethesda, MD, USA. · Pubmed 18704977
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, Department of Health and Human Services, Bethesda, MD 20892-1282, USA. · Pubmed 18435563
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. · Pubmed 18562287
12 Other Locations Show
Yearly article counts 000221241675
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.